a developer of novel drugs to treat intractable diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with NTLA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To ARWR | 1D Price Change % | ||
---|---|---|---|---|
ARWR | 100% | +0.56% | ||
NTLA - ARWR | 50% Loosely correlated | -3.24% | ||
BEAM - ARWR | 46% Loosely correlated | -1.57% | ||
EDIT - ARWR | 46% Loosely correlated | -3.58% | ||
CRNX - ARWR | 46% Loosely correlated | +0.24% | ||
PGEN - ARWR | 45% Loosely correlated | -3.57% | ||
More |
Ticker / NAME | Correlation To ARWR | 1D Price Change % |
---|---|---|
ARWR | 100% | +0.56% |
drugs theme (254 stocks) | 49% Loosely correlated | -1.72% |
diseases theme (41 stocks) | 44% Loosely correlated | -1.18% |
biotechnology theme (238 stocks) | 26% Poorly correlated | -1.80% |